Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

about

Epidermal Growth Factor Receptor Mutations and Their Prognostic Value with Carcinoembryonic Antigen in Pathological T1 Lung Adenocarcinoma.

P2860

Q55417810-7DC1C140-90FE-4E12-A906-651969657DC1

P2860

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

Item

http://www.wikidata.org/entity/Q36477758

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Identification of lung adenoca ...... ctive analysis of 269 patients

@ast

Identification of lung adenoca ...... ctive analysis of 269 patients

@en

type

Item

label

Identification of lung adenoca ...... ctive analysis of 269 patients

@ast

Identification of lung adenoca ...... ctive analysis of 269 patients

@en

prefLabel

Identification of lung adenoca ...... ctive analysis of 269 patients

@ast

Identification of lung adenoca ...... ctive analysis of 269 patients

@en

P1476

Identification of lung adenoca ...... ctive analysis of 269 patients

@en

P2093

Bin Dong

http://www.w3.org/2001/XMLSchema#string

Chao Lv

http://www.w3.org/2001/XMLSchema#string

Fangliang Lu

http://www.w3.org/2001/XMLSchema#string

Shanyuan Zhang

http://www.w3.org/2001/XMLSchema#string

Shaolei Li

http://www.w3.org/2001/XMLSchema#string

Yue Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.

Global cancer statistics, 2012

Pulmonary adenocarcinoma: a renewed entity in 2011

EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice

Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma.

Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis.

KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.

Annual report on status of cancer in China, 2010.

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.

P304

17-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1759-7714.12265

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26816535

http://www.w3.org/2001/XMLSchema#string

P932

4718135

http://www.w3.org/2001/XMLSchema#string

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

about

P2860

P2860

Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932